<

2016 Chinese medicine exports fell nearly 10%

  February 10, China Medicines and Health Products Import and Export Chamber of Commerce held a conference on pharmaceutical trade situation, according to China Customs statistics show that in 2016 China's pharmaceutical products import and export volume increased slightly, Chinese medicine imports and exports of 4.6 billion US dollars, accounting for pharmaceutical products The total import and export volume of 4.45%, Chinese medicine exports 34.26 billion US dollars, down 9.13%, imports of 1.174 billion US dollars, an increase of 14.50%.

  2016 Chinese medicine products, including Chinese herbal medicines and Pieces, proprietary Chinese medicines, extracts and health products, exports are plunged into negative growth, exports and exports "double down." Exports of health products amounted to US $ 249 million, down 13.22% year on year, and exports were US $ 1.997 billion, down 10.93% year on year. Exports of proprietary Chinese medicines were US $ 225 million, down 13.94% year on year. Exports of Chinese herbal medicines and Pieces were US $ 1.025 billion Down 3.13%.

  Extract exports accounted for 56.2% of the total exports of traditional Chinese medicine products, 2016, extract exports fell 14.3% year on year, exports fell 10.9% year on year, the main reason for the negative growth of Chinese medicine exports.

2016, China's health care products import and export volume of 103.4 billion US dollars, an increase of 0.73%. Among them, the export of 55.4 billion US dollars, down 1.82%, imports 48 billion US dollars, up 3.83 percent, foreign trade surplus of 7.4 billion US dollars, down 27.3 percent. Pharmaceutical trade growth of 7.12%, export growth of 4.41%, imports increased by 10.42%, leading the overall level of China's foreign trade.

  2016 China Pharmaceutical R & D Contract Outsourcing Service (CRO) market size reached 42 billion yuan, is expected in 2020 will be more than 87 billion yuan. On the one hand, the domestic CRO has grown, bear a large number of foreign drug research and development, clinical trial project, China has become Asia's most important multi-center clinical trial center. On the other hand, Chinese medicine services are constantly "going out". China Pharmaceutical Health Products Import and Export Chamber of Commerce Vice President Xu Ming introduction, 2016, China sent Chinese medicine clinicians about 2,000 people, accounting for 60% of the total number of medical staff. More than 60 Chinese medicine service trade institutions in more than 20 countries and regions to open Chinese medicine hospitals, Chinese medicine clinics, Chinese health care institutions, Chinese medicine research center, the annual admissions volume of 250,000 people.

  At present, the international pharmaceutical industry more detailed division of labor, enterprises and research institutes, foreign enterprises were normalized. Enterprises and partners in product development, registration declaration, product production, sales channels to promote their own advantages, to jointly develop the market. Xu Ming believes that 2016 Chinese medicine exports decline, the internationalization of traditional Chinese medicine must think about new ways, Chinese medicine complement each other, should play together, go out together.

  In 2016, by the external major economies sluggish demand, emerging market power shortage, price competition is becoming increasingly fierce and many other factors, pharmaceutical import and export into the low growth period, the difficulties and challenges can not be underestimated. At the same time, the pharmaceutical export structure to further optimize the pace of internationalization of enterprises to speed up the new development momentum is accumulating, the overall development of pharmaceutical foreign trade situation is still good.

【Disclaimer】
This article is reproduced, only for communication, does not represent the views of this site, Ben Wang is not responsible for the authenticity of the content, hereby declare. If the content, copyright and other issues involved, please contact the site within 30 days, we will be the first time to remove or replace the relevant content, but not related to compensation commitments. The copyright of this article and the content of the interpretation of the original author.